Summit Therapeutics Inc (SMMT)
4.955
-0.36
(-6.69%)
USD |
NASDAQ |
May 08, 16:00
4.955
0.00 (0.00%)
After-Hours: 20:00
Summit Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.4932 |
March 31, 2022 | 0.389 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.8534 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | |
March 31, 2020 | 0.00 |
October 31, 2019 | 0.00 |
Date | Value |
---|---|
July 31, 2019 | 0.00 |
April 30, 2019 | 0.00 |
January 31, 2019 | 0.00 |
October 31, 2018 | 0.00 |
July 31, 2018 | 0.00 |
April 30, 2018 | 0.00 |
January 31, 2018 | 0.00 |
October 31, 2017 | 0.00 |
July 31, 2017 | 0.00 |
April 30, 2017 | 0.00 |
January 31, 2017 | 0.00 |
October 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jul 2019
0.8534
Maximum
Mar 2021
0.1446
Average
--
Median
Jul 2019
Debt to Equity Ratio Benchmarks
Retractable Technologies Inc | 0.0155 |
BioCardia Inc | 0.00 |
Alpine Immune Sciences Inc | 0.00 |
Axsome Therapeutics Inc | 1.241 |
Krystal Biotech Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 176.78M |
Total Liabilities (Quarterly) | 132.57M |
Shareholders Equity (Quarterly) | 44.21M |